Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 21 (4) , 315-321
- https://doi.org/10.1097/00006454-200204000-00011
Abstract
Haemophilus influenzae type b (Hib) conjugate vaccines have successfully reduced the burden of invasive Hib disease in developed countries; however, their effectiveness in countries with a high incidence of pediatric HIV-1 is unknown. The effectiveness of Hib conjugate vaccine was prospectively evaluated in South African children. The burden of invasive Hib disease in children 197 The estimated burden of invasive Hib disease in nonimmunized HIV-1-infected children P Although the Hib conjugate vaccine was less effective among HIV-1-infected than among uninfected children, it was 83% effective in preventing overall invasive Hib disease and therefore should be considered for inclusion in the routine vaccination schedule by other African countries.Keywords
This publication has 18 references indexed in Scilit:
- Impact of human immunodeficiency virus type 1 infection on the epidemiology and outcome of bacterial Meningitis in South African childrenInternational Journal of Infectious Diseases, 2001
- Increased Disease Burden and Antibiotic Resistance of Bacteria Causing Severe Community-Acquired Lower Respiratory Tract Infections in Human Immunodeficiency Virus Type 1-Infected ChildrenClinical Infectious Diseases, 2000
- Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of ConjugatesClinical Microbiology Reviews, 2000
- The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected womenThe Pediatric Infectious Disease Journal, 1998
- Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infantsThe Lancet, 1997
- Persistence of Antibody Responses to Haemophilus influenzae Type b Polysaccharide Conjugate Vaccine in Children with Vertically Acquired Human Immunodeficiency Virus InfectionThe Pediatric Infectious Disease Journal, 1996
- Response of Human Immunodeficiency Virus–Exposed and–Infected Infants to Haemophilus influenzae Type b Conjugate VaccineArchives of Pediatrics & Adolescent Medicine, 1996
- Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infectionsThe Pediatric Infectious Disease Journal, 1996
- Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States populationThe Pediatric Infectious Disease Journal, 1995
- The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infantsThe Pediatric Infectious Disease Journal, 1995